MarketInOut Stock Screener Log In | Sign Up

Traws Pharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Traws Pharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.62 mln
Float10.86 mln
Earnings Date11/12/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

7 / 100
Severely lagging

ROE

-1,260
Deeply negative

ROA

-185
Deeply negative

Business Description

Traws Pharma Inc. is a clinical-stage pharmaceutical company based in Newtown, Pennsylvania, focused on developing oral pill-based treatments for viral respiratory illnesses and cancer. Its pipeline includes drugs targeting COVID-19, seasonal flu, and bird flu, as well as cancer treatments being studied in both solid tumors and blood cancers. The company works with several licensing partners and draws on research collaborations to advance its programs. Formerly known as Onconova Therapeutics, the company adopted its current name in April 2024 and has been operating since 1998.

Key Fundamentals

EPS-1.71
ROE-1,260
ROIC-685
ROA-185
EBITDA, mln-21.42
EV / EBITDA-0.22
EV / EBIT-0.22
Revenue, mln2.79
EV / Revenue1.70

Quote Details

Last 0.296
Change -0.005 (-1.66%)
Open 0.3098
Volume 198,706
Turnover 58,817
Average Volume 172,267

Financial Ratios

Current Ratio0.93
Price / Book5.47
Price / Sales1.81

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio0.48
Short % of Float5.29

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -13.58% 7 / 100   
1 Month -45.72% 5 / 100   
2 Months -43.08% 10 / 100   
6 Months -80.13% 5 / 100   
1 Year -89.35% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog